Therapeutic-area Dossier
Oncology
Therapeutic-area Dossier for Oncology (cancer medicines). Australian brands, active ingredients, PBS-listed treatments, PBAC outcomes — compiled by…
- Brand: ADRIAMYCIN
- Brand: AFINITOR
- Brand: AKYNZEO
- Brand: ALECENSA
- Brand: ALKERAN
- Brand: ALLMERCAP
- Sponsor: Arrotex Pharmaceuticals
- Sponsor: Dr Reddys Laboratories
- Sponsor: Accord Healthcare
- Sponsor: Cipla
What is
Oncology Oncology encompasses 800 brands registered in Australia, of which 565 are indexable.
Brands registered in Oncology The top brands in this area are:
— ABSTRAL — ACTIQ — ADCETRIS — ADRIAMYCIN — AFINITOR — ALDARA — ALECENSA — ALKERAN — ALLMERCAP — ALUNBRIG — APO-ANASTROZOLE — APO-TEMOZOLOMIDE
Sponsor landscape
The oncology therapeutic area has 121 active sponsors. Top sponsors include Arrotex Pharmaceuticals, Accord Healthcare, Cipla, Dr Reddy's Laboratories, Sandoz, Pfizer, Juno Pharmaceuticals, and Aspen Pharmacare.
PBS and regulatory activity
There are 206 brands with PBS-listed items in oncology, with the latest PBS schedule dated 1 May 2026. The most recent PBAC outcome in this area is from 1 December 2025, with 243 brands holding PBAC outcomes on record. The latest AusPAR is dated 26 March 2026, with 135 brands holding AusPARs on record.